2Jackson R, Reid JA,Thorbum J. Volume preloading is not essential to prevent spinal-induced hypotension at caesarean section[J].Br J anaesth, 1995,75(3) :262.
3Ueyama H, He YL, Tanigami H, et al. Effects of crystalloid and colloid preloid on blood volume in the parturient undergoing spinal anestheasia for elective cesarean section. Anesthesiology, 1999,91:571.
6Benumof J I. Pespiratory physiology and respiratory function during anestheasia[A]. In : Miller RD, ed. Anestheasia[C]. 5th ed. Philadlphia : Churchill Livingstone, 2000.578.
2[1]Baraka AS,Taha SK,Ghabach MB,et al.Intravascular adiministration of potymerized gelatin versus isotonic saline for prevention of spinal-induced hypotension.Anesth Analg,1994,78:301.
3Baraka AS,Taha SK,Ghabaeh MB, et al. Intravascular adiministration of polymerized gelatin versus isotonic saline for prevention of spinal-induced hypotension. Anesth Analy, 1994,78: 301.
4Waitzinger J,Bepperling F,Pabst G,et al.Hydroxyethyl starch(HES) 130/0.4,a new HES specification.Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers[J].Drug R&D,2003,4(3):149～157
5Boldt J,Brenner T,Lehmann A,et al.Influence of two different volume replacement regimens on renal function in elderly patients unergoing cardiac surgery:comparison of a new starch preparation with gelatin[J].Intensive Care Med,2003,29(5):763～769
6Neff TA,Doelberg M,Jungheinrich C,et al.Reptitive large dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury[J].Anesth Analg,2003,96(5):1453～1459
7Lang K,Suttner S,Boldt J,et al.Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing majorabdominalsurgery[J].Can J Anesth,2003,50(10):1009～1016
8Baron JF.A new hydroxyethyl starch:HES 130/0.4,voluven[J].Transfusion Alternatives in Transfusion Medicline,2000,2(2):13～21
9Waitzinger J,Bepperling F,Pabst G,et al.Effect of a new HES specification (6% HES130/0.4)on blood and plasma volumes after bleeding in 12 healthy male volunteers[J].Clin Drug Invest,1999,17(2):119～125
10Waitzinger J,Bepperling F,pabst G,et al.Phannacokinetics and tolerability of a new hydroxyethyl starch(HES) specification(HES130/0.4) specification(HES 130/0.4) after single dose infusion of 6 % or 10 % solution in healthy volunteers[J].Clin Drug invest,1998,16(2):151～160
